DrugPatentWatch Database Preview
Bempedoic acid; ezetimibe - Generic Drug Details
What are the generic sources for bempedoic acid; ezetimibe and what is the scope of freedom to operate?
Bempedoic acid; ezetimibe
is the generic ingredient in one branded drug marketed by Esperion Theraps Inc and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Bempedoic acid; ezetimibe has twenty-two patent family members in thirteen countries.
Summary for bempedoic acid; ezetimibe
| International Patents: | 22 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 4 |
| DailyMed Link: | bempedoic acid; ezetimibe at DailyMed |
Recent Clinical Trials for bempedoic acid; ezetimibe
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Esperion Therapeutics | Phase 2 |
| Esperion Therapeutics | Phase 3 |
US Patents and Regulatory Information for bempedoic acid; ezetimibe
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Theraps Inc | NEXLIZET | bempedoic acid; ezetimibe | TABLET;ORAL | 211617-001 | Feb 26, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Esperion Theraps Inc | NEXLIZET | bempedoic acid; ezetimibe | TABLET;ORAL | 211617-001 | Feb 26, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Esperion Theraps Inc | NEXLIZET | bempedoic acid; ezetimibe | TABLET;ORAL | 211617-001 | Feb 26, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Esperion Theraps Inc | NEXLIZET | bempedoic acid; ezetimibe | TABLET;ORAL | 211617-001 | Feb 26, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for bempedoic acid; ezetimibe
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | E036646 | Start Trial |
| Japan | 5593303 | Start Trial |
| Mexico | PA05007674 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2004067489 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
